Key takeaways
Levemir (insulin detemir) and NovoLog (insulin aspart) are both insulins used to manage diabetes, but they have different purposes and characteristics. Levemir is a long-acting insulin that helps control blood sugar levels for up to 24 hours and is typically injected once or twice daily. In contrast, NovoLog is a rapid-acting insulin that starts working within 15 minutes and is usually taken right before meals to manage blood sugar spikes from eating. Levemir is available in vials and FlexPens, while NovoLog comes in vials, prefilled pens, and can also be used in insulin pumps. Levemir is often used in combination with rapid-acting insulins like NovoLog for comprehensive blood sugar management. Both insulins can cause low blood sugar, but NovoLog's rapid action requires careful timing with meals to avoid low blood sugar. Levemir has a lower risk of weight gain compared to some other insulins, while NovoLog can lead to weight gain over time.
